Skip to main content

Table 1 Clinical, radiologic, and pathological characteristics of 11 cases with pituicytomas

From: Clinical features, radiological profiles, pathological features and surgical outcomes of pituicytomas: a report of 11 cases and a pooled analysis of individual patient data

No.

Sex

Age (year)

Signs and symptoms

Tumor location

Surgical approach

Extent of resection

Radiology

Postoperative complications

Immuno-histochemistry

PFS (mo)

Recurrence

1

M

46

Dizzy

Suprasellar

Craniotomy

GTR

Solid

Hypophysis, intracranial infection

S100(+), EMA(+), TTF-1(+), Ki-67 (2%)

12

No

2

F

46

None

Suprasellar

Craniotomy

GTR

Solid

Hypophysis

S100(+), GFAP(+), TTF-1(+), EMA(+), CD34(+), Ki-67 (1%)

34

Yes

3

F

47

Headache

Intrasellar

ETS

GTR

Solid

Hypophysis, intracranial infection

GFAP(+), TTF-1(+), CD34(+), S100(+), PR(+), EMA(+), Ki-67 (1%)

34

No

4

M

63

Vision loss

Intrasellar and suprasellar

ETS

STR

Uneven softness and toughness

None

S100(+), GFAP(+), TTF-1(+), EMA(+), Ki-67 (1%)

36

Yes

5

M

53

Vision loss

Intrasellar

Craniotomy

STR

Solid

None

S100(+), GFAP(+), TTF-1(+), EMA(+), vimentin(+), Ki-67 (1%)

88

Yes

6

M

32

Headache with decreased vision

Suprasellar

Craniotomy

GTR

Solid

Hypophysis

GFAP(+), S100(+), EMA(+), TTF-1(+), Ki-67 (1–3%)

24

No

7

F

51

Vision loss

Intrasellar

Craniotomy

STR

Uneven softness and toughness

Hypophysis

GFAP(+), S100(+), EMA(+), TTF-1(+), Ki-67 (1–5%)

22

Yes

8

F

65

None

Intrasellar and suprasellar

Craniotomy

STR

Soft

None

S100(+), GFAP(+), TTF-1(+), EMA(+), Ki-67 (1%)

12

No

9

F

38

Menstrual disorder

Suprasellar

Craniotomy

STR

Solid

None

GFAP(+), S100(+), EMA(+), TTF-1(+), CD34(+), Ki-67 (4%)

28

No

10

F

54

Headache

Intrasellar

ETS

GTR

Soft

None

S100(+), EMA(+), TTF-1(+), CD34(+), SMA(+), Ki-67 (1–3%)

22

No

11

M

47

Dizzy

Suprasellar

Craniotomy

GTR

Solid

Hypophysis and anemia

S100(+), EMA(+), TTF-1(+), Ki67 (2%)

16

No

  1. M Male, GTR Gross total resection, EMA Endomysial antibody, TTF-1 Thyroid transcription factor-1, F Female, GFAP Glial fibrillary acidic protein, PR Progesterone receptor, ETS Endoscopic transsphenoidal surgery, STR Subtotal resection, SMA Smooth muscle actin